Novozymes till Nebraska

Danmarks kronprinspar var på plats när det första spadtaget till den nya enzym- och etanolfabriken togs.

Nya rön kring Alzheimers

Alzheimers sjukdom orsakas av en fosterutvecklingsprocess som får nervceller att dö i den vuxna hjärnan enligt en ny studie.

Mot börsen med kassan full

Det norska cancerforskningsföretaget Algeta tar in 35 miljoner US-dollar för att fortsätta utvecklingen av sitt mest lovande cancerprojekt.

Antikropp mot leukemi

Genmab och Glaxosmithkline har ansökt om marknadsgodkännande hos EMEA för det biologiska leukemiläkemedlet Arzerra, med aktiv substans ofatumumab.

Avhopp i Probis top

Bolagets styrelseordförande lämnar sitt uppdrag.

Danskt stöd för ESS till Lund

Stödet växer för att den nya superforskningsanläggningen ska hamna i Lund. Den danska Läkemedelsindustriföreningen ställer sig nu bakom försöken att få ESS till Sverige. Tre kandidater tävlar om miljardsatsningen.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

Grant for development projects in Gothenburg

Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal that may lead to lay-offs of some 8,000 persons.

New CEO to Promedvi

Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.

Top modern lab to Sahlgrenska

The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.

Finnish-Dutch engineering cooperation continues

The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

Swedish multi competent machine soon launched

The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

LEO Pharma - International Clinical Trial Manager

View pathology images in your iPhone

The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.

DKK 1,3 billion for grand research

Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.

Trio goes in for high tech medicines

The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.

New influenza vaccine to EU

The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.

Mathematician new dean at DTU

On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.

Orion cuts 205 jobs

The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.